{"result": {"id": "2a020206-6bb1-4135-a919-4df547f5f165", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>HYPERTENSION<|>EVENT<|>A chronic medical condition characterized by elevated blood pressure, often associated with metabolic syndrome\")  \n##  \n(\"entity\"<|>OBESITY<|>EVENT<|>A medical condition involving excessive body fat, frequently comorbid with hypertension and metabolic syndrome\")  \n##  \n(\"entity\"<|>DIABETES<|>EVENT<|>A metabolic disorder characterized by high blood sugar, often linked to metabolic syndrome\")  \n##  \n(\"entity\"<|>CORONARY HEART DISEASE<|>EVENT<|>A cardiovascular condition increased by metabolic syndrome\")  \n##  \n(\"entity\"<|>STROKE<|>EVENT<|>A cerebrovascular event with elevated risk in metabolic syndrome patients\")  \n##  \n(\"entity\"<|>CHRONIC KIDNEY DISEASE (CKD)<|>EVENT<|>A renal condition exacerbated by metabolic syndrome\")  \n##  \n(\"relationship\"<|>HYPERTENSION<|>METABOLIC SYNDROME<|>Hypertension is a key diagnostic component of metabolic syndrome<|>8)  \n##  \n(\"relationship\"<|>OBESITY<|>METABOLIC SYNDROME<|>Obesity (particularly abdominal) is a core feature of metabolic syndrome<|>9)  \n##  \n(\"relationship\"<|>DIABETES<|>METABOLIC SYNDROME<|>Glucose abnormalities/diabetes are diagnostic criteria for metabolic syndrome<|>8)  \n##  \n(\"relationship\"<|>CORONARY HEART DISEASE<|>METABOLIC SYNDROME<|>Metabolic syndrome increases coronary heart disease risk by 1.51x in China<|>7)  \n##  \n(\"relationship\"<|>STROKE<|>METABOLIC SYNDROME<|>Metabolic syndrome elevates stroke risk by 1.20x<|>7)  \n##  \n(\"relationship\"<|>CHRONIC KIDNEY DISEASE (CKD)<|>METABOLIC SYNDROME<|>Metabolic syndrome raises CKD risk by 1.49x<|>7)  \n##  \n(\"relationship\"<|>GLP-1RA<|>OBESITY<|>GLP-1RA medications are used to treat obesity in metabolic syndrome<|>6)  \n##  \n(\"relationship\"<|>GIP/GLP-1 DUAL RECEPTOR AGONIST<|>DIABETES<|>This drug class manages diabetes in metabolic syndrome patients<|>6)  \n##  \n(\"relationship\"<|>HYPERTENSION<|>OBESITY<|>Obesity frequently coexists with and exacerbates hypertension<|>8)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558758, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 623, "prompt_tokens": 2858, "total_tokens": 3481, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2816}, "prompt_cache_hit_tokens": 2816, "prompt_cache_miss_tokens": 42}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 险没有差异[616] 。\n\n\n\n　8.8.2  其他干预措施   对于高血压合并肥胖的患者 ,  虽然不宜初始选择 GLP-1RA和葡萄糖依赖性促胰岛  素 多 肽 ( glucose-dependent insulinotropic polypep- tide,GIP)/GLP-1双受体激动剂用于患者的降压治  疗 ,但患者如有其他应用指征 , 即糖尿病和肥胖时 ,使  用这两类药物有助于患者的血压控制[617-618] 。在高血  压合并严重肥胖的患者中 ,减重代谢手术有助于控制  血压[619]  ,并减少降压药的种类和剂量[620]  ,但目前长  期预后研究的证据尚少。\n8.9   高血压合并代谢综合征\n\n要点 8I  高血压合并代谢综合征\n　　　·我国代谢综合征患病率高 ,且显著增加发生冠 心病、脑卒中和 CKD的风险。\n·代谢综合征治疗强调综合干预及全面达标。\n\n　　　我国代谢综合征的患病率已达 34% ,女性、老年、 低教育水平及经济发达地区的患病率较高 ,且农村地  区代谢综合征组分控制不理想 。在中国人群中 ,代谢  综合征致冠心病风险增加 1.51倍、脑卒中风险增加  1.20倍、CKD风险增加 1.49倍[621-622] 。\n　8.9.1  诊断标准和风险   具备以下 ≥3项即可作出 诊断 。 (1) 腹 型 肥 胖 : 腰 围 男 性 ≥ 90 cm, 女 性 ≥ 85 cm;(2) 血压增高 : 血压 ≥130/85mmHg和/或已 确诊为高血压并治疗者 ; (3) 血脂异常 : 空腹甘油三 酯≥1.70 mmol/L, 空腹 HDL-C<1.04 mmol/L, 或 确诊血脂异常并药物治疗者 ; (4) 血糖异常 : 空腹血 糖≥6.1 mmol/L或糖负荷后 2 h血糖≥7.8 mmol/L, 和/或已确诊为糖尿病并治疗者[623-624] 。肥胖合并高 血压和血脂异常是我国代谢综合征的最主要类型 , 占 53.7% ,其次 为 肥 胖 合 并 糖 代 谢 异 常 和 高 血 压 , 占 30.5%[625] 。\n　8.9.2  干预措施    (1)治疗原则 :早期综合干预 ,全面 达标 ;改善心血管与代谢异常并重 ;保护靶器官 ,减少 远期心血管风险[624] 。 (2) 生活方式改变 :健康膳食和 合理运动甚为重要和有效 。 国内社区人群研究显示 , 适当 增 加 运 动 可 降 低 代 谢 综 合 征 风 险  10% ~ 20%[626] 。 (3)药物治疗 :代谢综合征类型中以腹型肥 胖合并血脂紊乱者血压控制较差[627] 。降压药中推荐 优先应\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>GLP-1RA<|>ORGANIZATION<|>GLP-1RA is a type of medication used for treating diabetes and obesity, which can also aid in blood pressure control in hypertensive patients with these conditions\")  \n##  \n(\"entity\"<|>GIP/GLP-1 DUAL RECEPTOR AGONIST<|>ORGANIZATION<|>A medication class used for diabetes and obesity management, with potential benefits for blood pressure control in hypertensive patients\")  \n##  \n(\"entity\"<|>METABOLIC SYNDROME<|>EVENT<|>A cluster of conditions including obesity, hypertension, dyslipidemia, and glucose intolerance, increasing risks of cardiovascular and kidney diseases\")  \n##  \n(\"entity\"<|>CHINA<|>GEO<|>Country with a high prevalence of metabolic syndrome, especially among women, elderly, and rural populations\")  \n##  \n(\"relationship\"<|>GLP-1RA<|>METABOLIC SYNDROME<|>GLP-1RA is used to manage metabolic syndrome components like obesity and diabetes<|>6)  \n##  \n(\"relationship\"<|>GIP/GLP-1 DUAL RECEPTOR AGONIST<|>METABOLIC SYNDROME<|>This medication class helps address metabolic syndrome by targeting obesity and diabetes<|>6)  \n##  \n(\"relationship\"<|>METABOLIC SYNDROME<|>CHINA<|>China has a high prevalence of metabolic syndrome, particularly in specific demographic groups<|>4)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_738a695c7fc02faf91654e646c6ff75395a1cb9f0f78400aa7118d076af97c36_v2"}